Huangshi Mayor Wu Zhiling to Daye Peak Investigation
Release time:
2022-02-21
Daye Peak, as a backbone enterprise in Huangshi and a major taxpayer in Daye City, has been strongly supported by the governments of Huangshi City and Daye City for a long time, and fully affirmed the contribution of Daye Peak in promoting the local economic construction. This time, Mayor Wu Zhiling and his entourage made a special trip to Daye Peak to conduct an in-depth understanding of the current overall production and operation of the company and the actual difficulties faced by the company's development. Put forward opinions on the further development of the peak.
Mayor Wu Zhiling and his entourage also visited Daye Jianfeng Jinshan limestone mine, affirmed the restoration and management of the mine, and made a detailed understanding of the mine photovoltaic power generation project, requiring Daye Jianfeng to adhere to the development concept of "green water and green mountains are golden mountains and silver mountains", to restore and manage the mine ecology well, and to turn green mountains into real "golden mountains". Mayor Wu Zhiling hopes that Jianfeng Cement will accelerate its development, continue to contribute to local economic development, and inject new impetus into the high-quality development of Huangshi City. (Fan Liangwu)Another News
1 On the afternoon of
21, Vice Mayor Yang Zaorong of daye city led Dai Yilin, mayor of security, to daye peak cement company for investigation and discussion with Zhang Fengliang, deputy general manager of the group company and general manager of daye peak. At the meeting, Zhang Fengliang introduced the production and operation situation in 2021 and the problems existing in the development of the enterprise. Vice Mayor Yang Zaorong made work arrangements for the problems raised by the enterprise on the spot, and asked the Baoan Town government to draw up a schedule according to the problems raised at the meeting, issue the responsible person, and implement the time to solve the problems existing in the enterprise as soon as possible. Vice Mayor Yang Zaorong is very confident in the development of Daye Peak, and hopes that Daye Peak will continue its efforts in the future and make new and greater contributions to Daye's economic and social development. (Junin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31